Coverage / ITRMF / Trade Card

ITRMF

Iterum Therapeutics PLC

AVOID Analysis generated 2026-07-25 Market data as of unknown Market data date unknown USD 0.00 Healthcare - Biotechnology
BLOCKED - NOT ACTIONABLEMethodology gate: denylistCheck
29

Position levels

Currenttoday
USD 0.00
Buy <=wait / entry
-
Trim >=take some off
-
Thesis breaknot set
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case16%100 / 10016.0
Base case48%62 / 10029.8
Bear case36%10 / 1003.6
Weighted conviction29 / 100 - AVOID

Top risks

  • Commercial contract win with GPO linked to major PBM adding coverage for >40M lives starting early 2026
  • Japanese Patent Office Decision to Grant for sulopenem-related patent
  • High Court in Ireland appointed liquidators/restructuring officers on March 27 2026
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.

\n